Bioventix Market Cap

Bioventix has a market cap or net worth of 80.99 million as of March 6, 2026. Its market cap has decreased by -48.28% in one year.

Market Cap

80.99M

Enterprise Value

75.91M

Revenue

13.12M

Ranking

n/a

PE Ratio

10.82

Stock Price

1,518.00

Market Cap Chart

Since April 8, 2010, Bioventix's market cap has increased from 9.85M to 80.99M, an increase of 722.39%. That is a compound annual growth rate of 14.15%.

Market Cap History

Date	Market Cap	% Change
Mar 5, 2026	80.99M	-18.64%
Dec 31, 2025	99.53M	-39.94%
Dec 31, 2024	165.72M	-26.16%
Dec 29, 2023	224.45M	7.98%
Dec 30, 2022	207.85M	17.35%
Dec 31, 2021	177.12M	-22.46%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
4basebio	89.77M
Hemogenyx Pharmaceuticals	65.22M
Faron Pharmaceuticals Oy	61.94M
hVIVO	54.57M
Ondine Biomedical	53.25M
Scancell Holdings	135.95M
ImmuPharma	38.91M
Poolbeg Pharma	31.73M

Market Cap Rankings